Web Search Site Search New HIV/Aging Research Grants click here for details   Dolutegravir Expanded Access Program Open Now click here for details   3rd International Workshop on HIV & Aging, Baltimore, MD, USA, 5 - 6 November 2012. click here for details   NIH/NIAID HIV/AIDS & Aging Funding/Studies click here for details   Ryan White Care Act Hepatitis C & B Language (click here for details)   Current HIV Articles and News Updates     HIV     Sangamo BioSciences Presents Clinical Data Demonstrating HIV Reservoir Reduction in HIV-Infected Subjects Treated with ZFP Therapeutic®, SB-728-T - (05/22/13)   CROI: Aging with HIV: Where do we stand after CROI 2013? David Alain Wohl, MD - Associate Professor, Division of Infectious Diseases, The University of North Carolina at Chapel Hill - (05/20/13)   14th Intrntnl Wrkshp Clinical Pharm HIV Therapy Clinical Pharmacology at the 14th Workshop on Clinical Pharmacology of HIV Therapy and HCV - Courtney V. Fletcher, Pharm.D. Dean and Professor College of Pharmacy University of Nebraska Medical Center - (05/20/13)   13th Intrntnl Wrkshp Clinical Pharm HIV Therapy Darunavir Dosing Determined for Naive and Experienced Children and Teens - written by Mark Mascolini - (04/29/13)   13th Intrntnl Wrkshp Clinical Pharm HIV Therapy No Clinically Significant Interactions Between Boceprevir or Telaprevir and Dolutegravir - written by Mark Mascolini - (04/29/13)   13th Intrntnl Wrkshp Clinical Pharm HIV Therapy Protease Inhibitors Boost Levels of Cenicriviroc, a CCR5/CCR2 Antagonist - written by Mark Mascolini - (04/29/13)   13th Intrntnl Wrkshp Clinical Pharm HIV Therapy Ribavirin Trough Affects Early HCV Response With Unfavorable IL28B Profile - written by Mark Mascolini - (04/29/13)   More HIV Articles...         News Updates     Gilead Receives Complete Response Letters from U.S. Food and Drug Administration for Elvitegravir and Cobicistat - (05/1/13)   University of Minnesota doctors try to cure boy of HIV, cancer in risky operation - (04/22/13)   No confirmed link between Okla. clinic, diseases - (04/20/13)   Medicare drug rebate bills enter US Congress - (04/18/13)   More News Updates Articles...     Current Hepatitis C and B Articles     Hepatitis C     As Hepatitis C Spreads, Scotland Steps In: HCV Action Plan by Scotland - (05/22/13)   Twice Daily Telaprevir in Combination With Peginterferon Alfa-2a/Ribavirin in HCV Genotype 1 Liver Transplant Recipients: Interim Pharmacokinetics of the REFRESH Study - (05/22/13)   European Medicines Agency Validates Gilead's Marketing Application for Sofosbuvir for the Treatment of Hepatitis C - (05/22/13)   Twice-Daily Telaprevir in Combination with Peginterferon Alfa-2a/Ribavirin in HCV Genotype 1 Liver Transplant Recipients: Interim Safety/Efficacy of the REFRESH Study - (05/22/13)   FDA Approves FibroScan® for Non-invasive Liver Diagnosis - (05/22/13)   DDW: Simeprevir with Peginterferon/ribavirin for Treatment of Chronic HCV Genotype 1 Infection in Patients Who Relapsed After Previous Interferon-based Therapy: Results from PROMISE, a Phase III Trial - (05/22/13)   DDW: Response to 3 DAAs + RBV by Patient Characteristics: INTERFERON-FREE REGIMENS OF ABT-450/r, ABT-267, ABT-333, AND RIBAVIRIN ACHIEVE HIGH SUSTAINED VIROLOGIC RESPONSE 12 WEEKS POST-TREATMENT (SVR12) RATES IN PATIENTS WITH CHRONIC HCV GENOTYPE 1 REGARDLESS OF RACE, ETHNICITY, OR OTHER BASELINE CHARACTERISTICS - (05/21/13)   DDW: Key Drivers and Barriers to Treatment Initiation and Adherence in Individuals with Hepatitis C - (05/21/13)   DDW: Prevalence, Treatment, and Comorbidities of Hepatitis C Infection (HCV) Among Patients With Commercial and Medicaid Insurance - (05/21/13)   DDW: Final Results PROVIDE Study - (05/21/13)   DDW: An Analysis of Response Rates by Fibrosis Stage in Patients Treated With Faldaprevir, BI 207127, and Ribavirin in the SOUND-C2 Study - (05/20/13)   More Hep C Articles...         Hepatitis B     EASL: 5-year Entecavir treatment in NUC-naïve, field-practice patients with CHB showed excellent viral suppression and safety profile but no prevention of HCC in cirrhotics - (05/15/13)   EASL: Liver Disease in HBV-HIV Coinfection- Significant Fibrosis is Present Despite HBV Suppression and Anti-Retroviral Therapy - (05/15/13)   EASL: Virological Response Does Not Lower Liver Disease Progression Among Chronic Hepatitis B Cirrhotic Patients Treated with Long-Term Nucleo(t)ide-Analogue - (05/15/13)   EASL: INCIDENCE AND CLINICAL CONSEQUENCES OF REDUCED TUBULAR PHOSPHATE REABSORPTION IN NAIVE CHB PATIENTS TREATED WITH TENOFOVIR: A TWO-YEAR FIELD STUDY - (05/15/13)   EASL: HARPE Study: Prevalence of Renal Abnormalities in Chronic Hepatitis B Virus Infection - (05/15/13)   EASL: FROM COMBINATION-THERAPY TO MONO-THERAPY IN TREATMENT EXPERIENCED CHB PATIENTS WITH VIRAL RISISTENCE OR PARTIAL RESPONSES: FIRST RESULTS OF AN INTERNATIONAL MULTICENTER COHORT STUDY - (05/15/13)   EASL: Entecavir plus tenofovir combination as rescue therapy in pre-treated chronic hepatitis B patients: An international multicenter cohort study - (05/15/13)   More Hep B Articles...   Check Out Our Special NATAP Features   Link to conference listings CROI 2013 - 20th Conference on Retroviruses and Opportunistic Infections http://retroconference.org/ Conference on Retrovirueses and Opportunistic Infections 11th European Mtg on HIV & Hepatitis - Treatment Strategies & Antiviral Drug Resistance 20- 22 March 2013, Rome, Italy 14th International Workshop on Clinical Pharmacology of HIV Therapy 22 - 24 April 2013 (prior the the EASL conference) EASL 2013 - 48th Annual Meeting of the European Association for the study of the Liver April 24-28 Amsterdam, Netherlands 2nd Asian Conference on Hepatitis and HIV From basic science to clinical practice 10 & 11 May 2013 Beijing, China DDW - Digestive Disease Week May 18-21 2013 Orlando, FL 2nd Latin American Meeting on Treatment of Viral Hepatitis 24-25 May 2013 Sheraton Hotel WTC Convention Center, Sao Paulo, Brazil 9th International Workshop on HIV & Hepatitis Co-infection 30 - 31 May 2013 Venue: Trevi Fountain Conference Centre, Rome, Italy Workshop on HIV & Viral Hepatitis - Drug Resistance and Curative Strategies June 4-8 2013 - Toronto, Canada http://www.informedhorizons.com/ HIV in the Americas Congress June 13-15 2013, Sao Paulo Brazil www.hivamericas.org 23rd Conference of the Asian Pacific Association for the Study of the Liver (APASL) 8th International Workshop on Clinical Pharmacology of Hepatitis Therapy 26 - 27 June 2013 Hyatt Regency Hotel, Cambridge MA, USA 8th International Workshop on Hepatitis C Resistance & New Compounds 27 - 28 June 2013 Hyatt Regency Cambridge Hotel, Cambridge, MA, USA 5th International Workshop on HIV Pediatrics 28 and 29 June 2013 Location: tba, Kuala Lumpur, Malaysia IAS 2013 - International AIDS Society June 30-July 3 2013 Kuala Lumpur, Malaysia http://www.ias2013.org/Default.aspx?pageId=409 ICAAC 2013 - 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy Sept 10-13 Denver, Colorado http://www.asm.org/index.php/component/content/article/91433 IDWeek 2013 October 2-6 2013 San Francisco, CA http://www.idweek.org/ HCV2013 - 20th International Symposium on Hepatitis C Virus and Related Viruses October 8th - 10th 2013 Melborne 15th International Workshop on Co-morbidities and Adverse Drug Reactions in HIV Oct 15-17 2013 Brussels http://www.intmedpress.com/comorbidities/ EACS 2013 - 14th European AIDS Conference October 16-19 Brussels, Belgium http://www.eacs-conference2013.com/index.php?id=40 4th International Workshop on HIV & Aging 30 - 31 October 2013 Baltimore, MD, USA http://www.virology-education.com/index.cfm/t/4th_International_Workshop_on_HIV___Aging/vid/4DBBCE6B-DF9A-9A35-05E2D394DE720BFC AASLD - the 64th Annual Meeting of the American Association for the study of Liver Diseases Nov 1-5 Washington DC http://www.aasld.org/Pages/Default.aspx Sixth International HIV Persistence Workshop December 3-6 2013, Miami, Florida http://www.hiv-workshop.com/workshop-2013.htm HEP DART 2013 - frontiers in drug development for viral hepatitis December 8-12 2013 - The Fairmont Orchid Big Island, Hawaii http://www.informedhorizons.com/hepdart2013/default.aspx 3rd Global Workshop on HCV Therapy Advances New Antivirals in Clinical Practice 13-14 December 2013 Rome, Italy (t.b.c.) Digestive Disease Week (DDW) May 18-21, 2013 Orlando, FL   14th International Workshop on Clinical Pharmacology of HIV Therapy April 22-24, 2013 The Netherlands, Amsterdam   EASL 48th Annual Meeting April 24th - 28th 2013 The Netherlands, Amsterdam   CROI: 20th Conference on Retroviruses and Opportunistic Infections Atlanta, GA March 3 - 6, 2013   Third International Workshop on HIV and Women January 14-15, 2013 Toronto 11th International Congress on Drug Therapy in HIV Infection 11-15 November 2012 Glasgow, UK 63rd Annual Meeting of the American Association for the Study of Liver Diseases Boston, MA Nov 9-12 2012 3rd International Workshop on HIV and Aging November 5-6, 2012 Baltimore MD IDSA Conference (Infectious Disease Society Association) San Diego, CA Oct 17-21 2012 52nd ICAAC Interscience Conference on Antimicrobial Agents and Chemotherapy September 9-12, 2012, San Francisco XIX International AIDS Conference July 22-27, 2012 Washington, DC   14th International Workshop on Co-morbidities and Adverse Drug Reactions in HIV Washington DC, July 19-21 2012   International Workshop on HIV & Hepatitis Virus Drug Resistance 5-9 June 2012, Sitges, Spain   EASL 47th Annual Meeting Barcelona, Spain April 18th - 22nd 2012   13th International Workshop on Clinical Pharmacology of HIV Therapy Barcelona, Spain April 16-18, 2012   CROI: 19th Conference on Retroviruses and Opportunistic Infections Seattle, WA March 5 - 8, 2012   The 22st Conference of the Asian Pacific Association for the Study of the Liver APASL Feb 16-19, 2012 Taipei, Taiwan   2nd International Workshop on HIV & Women January 9-10, 2012 Bethesda, Maryland   HepDART 2011 Kauai, HI USA December 4, 2011 - December 8, 2011   62th Annual Meeting of the American Association for the Study of Liver Diseases San Francisco 2011 Nov 6-9   Second International Workshop on HIV and Aging Baltimore, MD October 27-28, 2011   EACS - 14th European AIDS Conference European AIDS Conference Oct 12-15 2011 Belgrade, Serbiay   51th ICAAC Interscience Conference on Antimicrobial Agents and Chemotherapy Chicago, IL September 17-20, 2011   6th IAS Conference on HIV Pathogenesis Treatment and Prevention July 17-20, 2011, Rome   13th Intl Workshop on Adverse Reactions & Comorbidities in HIV July 2011-Rome, Italy   The 6th International Workshop on Clinical Pharmacology of Hepatitis Therapy Boston, MA June 22-23, 2011   International Workshop on HIV & Hepatitis Virus Drug Resistance and Curative Strategies June 7- 11, Cabo, Mexico   12th International Workshop on Clinical Pharmacology of HIV Therapy, April 13-15, 2011, Miami, FL   Eurpopean Association for the Study of the Liver March 30th - April 3rd 2011 Berlin, Germany   18th CROI Conference on Retroviruses and Opportunistic Infections February 27 - March 2, 2011 Boston, MA   The 21st Conference of the Asian Pacific Association for the Study of the Liver APASL Feb 17-20, 2011 Bangkok, Thailand   1st International Workshop on HIV and Women, January 10-11, 2011 Washington, DC   12th Intl Workshop on Adverse Reactions & Comorbidities in HIV November 5, 2010 London UK   10th International Congress on Drug Therapy in HIV Infection Glasgow November 7-11, 2010   61th Annual Meeting of the American Association for the Study of Liver Diseases Boston, MA, Hynes Convention Center October 30-November 3, 2010   First International Workshop on HIV and Aging October 4-5, 2010 Baltimore, MD   (ICAAC) 50th Interscience Conference on Antimicrobial Agents and Chemotherapy September 12-15 2010 Boston, MA   AIDS 2010 18th International AIDS Conference (IAC) July 18-23 2010 Vienna, Austria   5th International Workshop on Hepatitis C Resistance and New Compounds Boston, MA June 24-25, 2010   The 5th International Workshop on Clinical Pharmacology of Hepatitis Therapy Boston, MA June 23-24, 2010   International HIV and Hepatitis Drug Resistance Workshop June 8-12, 2010 Dubrovnik Croatia   Microbicides Conference May 22-25, 2010 Pittsburgh, Pennsylvania   EASL 45th Annual Meeting (European Association for the Study of the Liver) April 14-18, 2010 Vienna, Austria   11th International Workshop on Clinical Pharmacology and HIV Therapy April 7-9, 2010 Sorrento, Italy   Conference of the Asian Pacific Association for the Study of the Liver 2010 20th APASL March 2010 Beijing, China   17th CROI Conference on Retroviruses and Opportunistic Infections San Francisco, CA Feb 16-19, 2010   View More Conference Reports...   Coming of AGE. A guide to ageing well with HIV - 06/15/11 La informacion Que Necesitas Sobre el VIH - 06/15/10 New Goals and New Drugs for People With Heavy Anti-HIV Drug Experience - 06/05/07 Do you have HIV/HCV Coinfection? - 11/28/06 HIV 101 : The Basics - 11/28/06 VIH 101 : Lo Basico - in Spanish - 11/28/06 HIV 102 : Care and Treatment of HIV - 11/28/06 VIH 102 : Cuidado Y Tratamiento del VIH - in Spanish - 11/28/06 Hepatitis C and Hepatitis C Co-Infection Handbook PDF Version V 11/08/05 Download More NATAP Publications... Support provided by: Abbott, Boehringer-Ingelheim, Bristol-Myers Squibb, Gilead, GlaxoSmithKline, Merck, Roche, Schering-Plough, Tibotec, Vertex   Patient Assistance Programs for HCV Therapy from the Drug Manufacturers: Pegylated Interferon and ribavirin If you cannot get reimbursement or coverage for pegylated interferon and ribavirin the manufacturers of pegylated interferon have reimbursement programs which supply free drugs if you qualify. These programs will first help you try to identify sources for reimbursement.   Schering makes Peg-Intron and ribavirin (Rebetol): Call 1-800-521-7157. Roche makes Pegasys and ribavirin (Copegus): 1-800-387-1258.   New Pegasys Patient Assistance Program   has generous provisions for patients who want to start HCV therapy with Pegasys and are uninsured. Since Roche & Genentech merged the Genentech Access Solutions P rogram took over this program starting Sept 1 2010 and as I say it is a generous transparent program.   http://www.pegasysaccesssolutions.com   866 422-2377